©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: AJA001
DeFloria Receives Investigational New Drug Application Clearance for Autism Spectrum Disorder
LITTLETON, Colo. -- U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug (IND) application for AJA001, an orally delivered,...
DeFloria LLC Commences Phase 1 Clinical Program for Full Spectrum Hemp Botanical Drug
DENVER - Charlotte's Web Holdings Inc., A market leader in full-spectrum hemp extract wellness products, and AJNA BioSciences PBC, a botanical drug development company focused...







